Companies /Real Estate

Ventas Inc

NYSE: VTR Reit - Healthcare Facilities
$90.27
▼ $1.84 (−2.00%) today
Markets closed · 8:39am ET

Q3 2025 Earnings

Reported Oct 29, 2025, 4:23pm ET · SEC source
$0.14
Beat +180.00%
EPS · est. $0.05
$1.5B
Beat +3.72%
Revenue · est. $1.4B
+7.4%
Beating market
VTR vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+3%+6%Oct 29Oct 30report 4:23pm ETearnings−0.4%+4.2%
0+3%+6%Oct 29Oct 30earnings−0.4%+4.2%
VTR +4.2%S&P 500 −0.4%
0+3%+6%Oct 29Oct 30report 4:23pm ETearnings−0.3%+4.2%
0+3%+6%Oct 29Oct 30earnings−0.3%+4.2%
VTR +4.2%NASDAQ −0.3%
−3%0+3%+6%Oct 28Nov 6report 4:23pm ETearnings−2.1%+6.9%
−3%0+3%+6%Oct 28Nov 6earnings−2.1%+6.9%
VTR +6.9%S&P 500 −2.1%
−4%0+4%+8%Oct 28Nov 6report 4:23pm ETearnings−3.4%+6.9%
−4%0+4%+8%Oct 28Nov 6earnings−3.4%+6.9%
VTR +6.9%NASDAQ −3.4%
+6.56%
Day of report
−0.77%
Next session
+0.79%
One week
+7.69%
30 days

S&P 500 over the same 30 days: +0.25%.

Did VTR Beat Earnings? Q3 2025 Results

Ventas delivered a standout third quarter in 2025, posting earnings per share of $0.14 against a consensus estimate of just $0.05, a beat of 180.00%, while revenue of $1.49 billion topped the $1.44 billion estimate by 3.72% and climbed 20.4% year-over-year. The driving force behind the results was unmistakable: the company's senior housing operating portfolio surged, with same-store cash NOI growing 16% year-over-year and U.S. SHOP contributing 19% growth, fueled by a 270-basis-point occupancy expansion and improving margins from Ventas's proprietary operating platform. Net income attributable to common stockholders jumped to $66.05 million from $19.24 million a year earlier, a 243% increase, while normalized FFO per share rose 10% to $0.88. Management raised its full-year normalized FFO guidance to $3.45 to $3.48 per share and lifted its 2025 senior housing investment target to $2.50 billion, signaling confidence that secular tailwinds from an aging population and historically low new supply will sustain the momentum well into the years ahead.

Key Takeaways
  • SHOP same-store cash NOI grew 16% year-over-year, led by U.S. growth of 19%
  • Same-store average occupancy grew 270 basis points year-over-year and 160 basis points sequentially
  • U.S. same-store average occupancy grew 340 basis points year-over-year and 200 basis points sequentially
  • SHOP same-store cash NOI margin expanded 200 basis points year-over-year
  • Ventas OI platform deployment driving operational efficiency
  • Total Company NOI year-over-year growth of 20%
  • Total Company Same-Store Cash NOI year-over-year growth of 8%
  • Normalized FFO per share increased 10% year-over-year

“Ventas delivered strong financial performance and growth in the third quarter as we continued to execute on our 1-2-3 strategy. Results in the quarter were powered by our senior housing operating portfolio (SHOP), which experienced broad-based demand and grew organically year-over-year by double digits.”

Ventas CEO, on the earnings call

Forward Guidance & Outlook

Ventas raised its full-year 2025 guidance: Normalized FFO per share is now expected in the range of $3.45 to $3.48 (midpoint $3.47), up from the prior range of $3.41 to $3.46. Attributable Net Income per share is expected at $0.49 to $0.52 (midpoint $0.51), up from $0.47 to $0.52. Nareit FFO per share is guided at $3.43 to $3.46 (midpoint $3.45). The company increased its 2025 senior housing investment volume target to $2.5 billion from $2.0 billion. Key guidance assumptions include ~$2.6 billion of equity raised, G&A expenses of ~$178 million, interest expense of ~$615 million, full-year weighted average diluted share count of 462 million, disposition proceeds of ~$250 million, and FAD capital expenditures of ~$285 million. Growth is driven by SHOP NOI strength and accretive senior housing investments.

VTR YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$500.0M$1.0B$1.5B$1.2B$1.5BRevenue$19.2M$66.0MNet Income
$0$500.0M$1.0B$1.5BRevenueNet Income

VTR Revenue by Segment

Senior Housing Operating Portfolio (SHOP)
Outpatient Medical and Research (OM&R)
Triple-Net Leased Properties (NNN)

Figures from SEC filings and company reports. Not investment advice.